ASCO 2023 – New Data Highlights Three Studies Showing The Impact Of Vitrakvi On Long-Term Efficacy & Safety In Adult And Pediatric Patients

Dr. Svetlana Babajanyan, MD, Executive Medical Director of Medical Affairs for Oncology at Bayer U.S. Pharmaceuticals discusses new findings from three separate studies analyzing the safety & efficacy of Vitrakvi (larotrectinib) in pediatric and adult patients. These data were presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

Read More

Dr. Erica P. Gunderson Named 2022-2023 March of Dimes Agnes Higgins Award Winner

Dr. Erica P. Gunderson, ​PhD, MS, MPH, Senior research scientist at Kaiser Permanente Northern California Division of Research and a professor of Health Systems Science at Kaiser Permanente Bernard J. Tyson School of Medicine discusses being named the recipient of the 2022-2023 March of Dimes Agnes Higgins Award in Maternal-Fetal Nutrition. Her work has produced some of the field’s most important and astounding findings on pregnancy and breastfeeding’s links to diabetes and cardiovascular disease in young women. She received the award at the annual meeting of the Pediatric Academic Society (PAS).

Read More

​Legacy Healthcare – Botanical Drugs

Saad Harti, founder and CEO of Swiss-based biotech Legacy Healthcare discusses the company’s positive Phase 2/3 data and filing of their lead prescription botanical drug Coacillium for the treatment of an autoimmune condition, alopecia areata. He also talks about a recent survey which found that patients would prefer prescription botanical drugs to treat their chronic diseases.

Read More

Genmab and AbbVie Present New Epcoritamab Data at EHA 2023

Dr. Reid Merryman, MD, an attending physician in the Lymphoma Program at the Dana-Farber Cancer Institute discusses Genmab and AbbVie’s preliminary data from its ongoing phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in patients across B-Cell lymphomas that were presented at the European Hematology Association’s (EHA) Annual Meeting 2023.   Read the abstract here.

Read More